Viji Finance Limited has received trading approvals from BSE Limited and National Stock Exchange of India Limited for 2.95 crore equity shares. The shares, issued at a premium of ₹1.80 per share on a preferential basis pursuant to warrant conversion, will be admitted for trading effective September 29, 2026.

The company filed an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the receipt of these approvals. This follows an earlier disclosure dated September 12, 2026, regarding the listing approval for the same block of shares.

Share Details and Issuance Terms

The approved securities consist of equity shares with a face value of ₹1 each. These shares were allotted to non-promoters through the conversion of warrants. The specific details of the issuance are outlined below:

Lock-in Periods for Allottees

The NSE listing letter specified lock-in periods for the allotted shares, which vary slightly by tranche but generally extend until March 31, 2027. The table below summarizes the lock-in details provided in Annexure I:

Regulatory Compliance and Approvals

BSE Limited issued its trading approval via Letter No. LOD/PREF/VJ/403/2026-27 dated September 28, 2026. Similarly, NSE Limited confirmed the listing through Letter No. NSE/LIST/57523 on the same date. Both exchanges directed the company to ensure all critical price-sensitive information is submitted through their respective electronic filing systems.

The Chairman and Managing Director, Vijay Kothari, signed the intimation to the exchanges, confirming that copies of the approval letters were enclosed for record purposes. The shares are now listed and admitted to dealings on both exchanges in accordance with the terms specified in the approval letters.

Viji Finance has recommended the appointment of DDS & Associates as its statutory auditor to fill a casual vacancy on the board. The recommendation was made by the Board of Directors on September 2, 2026, following the resignation of the previous auditors, Dharmendra K Agarwal & Co.

The appointment is subject to approval by the company's members in a general meeting convened within the period prescribed under Section 139(8) of the Companies Act, 2013. If approved, DDS & Associates will hold office until the conclusion of the next Annual General Meeting.

Auditor Details

The new statutory auditor, DDS & Associates, is a proprietorship firm based in Ahmedabad, Gujarat. It holds Firm Registration No. 120362W with the Institute of Chartered Accountants of India (ICAI).

The firm is peer-reviewed and empanelled with the Comptroller and Auditor General (CAG) under Empanelment No. WR3752 since the 2009-10 fiscal year. It has also been empanelled with the RBI’s Master Empanelment Framework (MEF) under Empanelment No. 81367 since 2007-08.

Scope of Practice

DDS & Associates offers audit and assurance services, income tax consultancy, GST compliance, and corporate advisory. The firm has experience serving listed companies, NBFCs, and government entities. It previously served as a Banking Statutory Branch Auditor from 2019-20 to 2023-24.

The disclosure confirmed that DDS & Associates has no relationship with any of the directors of Viji Finance Ltd.